1. Ketanserin combined with a beta-blocker or diuretic in essential hypertension. A multicentre study

   • C. Bartoloni
   • P. Dupont
   • J. Symoens

   Originals Pages: 573 - 577

2. Simvastatin and bezafibrate: Effects on serum lipoproteins and lecithin: Cholesterol acyltransferase activity in familial hypercholesterolaemia

   • P. Weisweiler

   Originals Pages: 579 - 583

3. Acute effects of amitriptyline on human performance and interactions with diazepam

   • A. Patat
   • M. J. Klein
   • J. Granier

   Originals Pages: 585 - 592

4. Interaction of alcohol with maprotiline or nomifensine: Echocardiographic and psychometric effects

   • C. Strömberg
   • A. Suokas
   • T. Seppälä

   Originals Pages: 593 - 599

5. Effect of lithium treatment on the GH-clonidine test in affective disorders

   • F. Brambilla
   • M. Catalano
   • E. Smeraldi

   Originals Pages: 601 - 605

6. Effect of acute administration of propranolol and atenolol on baroreflex function in normal man

   • A. H. Deering
   • D. W. G. Harron
   • R. G. Shanks

   Originals Pages: 607 - 612

7. Penbutolol: Pharmacokinetics, effect on exercise tachycardia, and in vitro inhibition of radioligand binding

   • D. Brockmeier
   • P. Hajdù
   • A. Wellstein

   Originals Pages: 613 - 623

8. In vivo and in vitro studies of the site of inhibitory action of omeprazole on adrenocortical steroidogenesis

   • L. J. Dowie
   • J. E. Smith
   • C. J. Kenyon

   Originals Pages: 625 - 629

9. The relationship between pharmacokinetics and pharmacodynamics of enoximone in healthy man

   • G. G. Belz
   • T. Meinicke
   • M. Schäfer-Korting

   Originals Pages: 631 - 635

10. Dosage guidelines for the use of vancomycin based on its pharmacokinetics in infants

    • S. M. Lisby-Sutch
    • M. C. Nahata

    Originals Pages: 637 - 642

11. Use of mannitol during neurosurgery: Interpatient variability in the plasma and CSF levels

    • P. Anderson
    • L. Boréus
    • G. Öhman

    Originals Pages: 643 - 649

12. 4-quinolones inhibit biotransformation of caffeine

    • S. Harder
    • A. H. Staib
    • P. M. Shah

    Originals Pages: 651 - 656

13. Creation of four consecutive instantaneous steady-state plasma concentration plateaus of theophylline and enprofylline by repeated infusions with exponentially decreasing delivery rates

    • J. Kraan
    • L. Borgström
    • O. E. de Noord

    Originals Pages: 657 - 661

14. Multi-variate analysis of factors governing the pharmacokinetics of exogenous factor VIII in haemophiliacs

    • A. Messori
    • G. Longo
    • P. Rossi Ferrini

    Originals Pages: 663 - 668

15. Bronchodilator effect and serum theophylline level after combined treatment with fenoterol and theophylline in reversible chronic airflow obstruction

    • M. I. Lucena
    • J. Almagro
    • F. Sanchez de la Cuesta

    Short Communications Pages: 669 - 671

16. Safety and pharmacokinetics of mifentidine after increasing oral doses in healthy subjects

    • B. P. Imbimbo
    • M. Seiberling
    • S. Daniotti

    Short Communications Pages: 673 - 676

17. A comparison of the pharmacokinetics of mefloquine in healthy Thai volunteers and in Thai patients with falciparum malaria

    • J. Karbwang
    • D. J. Back
    • A. M. Breckenridge

    Short Communications Pages: 677 - 680

18. The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution

    • G. Edwards
    • A. Dingsdale
    • A. M. Breckenridge

    Short Communications Pages: 681 - 684

19. Respiratory depression due to MST

    • Z. Niazi
    • B. Mooney
    • S. O'Domhnaill

    Short Communications Pages: 685 - 685

20. Pre-trial drop-outs

    • A. Kaldor
    • B. Gachályi
    • A. Vas

    Letter To The Editors Pages: 686 - 686